<?xml version="1.0" encoding="UTF-8"?>
<ref id="B95">
 <label>95.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Kurogi</surname>
    <given-names>H</given-names>
   </name>
   <name>
    <surname>Inaba</surname>
    <given-names>Y</given-names>
   </name>
   <name>
    <surname>Takahashi</surname>
    <given-names>E</given-names>
   </name>
   <name>
    <surname>Sato</surname>
    <given-names>K</given-names>
   </name>
   <name>
    <surname>Goto</surname>
    <given-names>Y</given-names>
   </name>
   <name>
    <surname>Satoda</surname>
    <given-names>K</given-names>
   </name>
   <etal/>
  </person-group>. 
  <article-title>Development of inactivated vaccine for Akabane disease</article-title>. 
  <source>Natl Inst Anim Health Q.</source> (
  <year>1978</year>) 
  <volume>18</volume>:
  <fpage>97</fpage>â€“
  <lpage>108</lpage>.
  <?supplied-pmid 740047?>
  <pub-id pub-id-type="pmid">740047</pub-id>
 </mixed-citation>
</ref>
